Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF10A |
Human breast fibrocystic disease cell line | ATCC CRL-10317 | Human | breast | cell line | adherent | plasmid | Metafectene PRO | publication | L. Qin et al., Cell Reports, 2015,13: 2056-2063; doi.org/10.1016/j.celrep.2015.11.015 | Link | ||
MDA-MB-157 |
Human breast carcinoma cell line | ATCC HTB-24 | Human | breast | cell line | adherent | plasmid | Metafectene PRO | publication | V. Vella et al., Oncotarget, 2017, 8 (26): 43248-43270 | Link | ||
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | plasmid | Metafectene PRO | publication | A. Ray et al., Mol. Cancer Res., Aug 2011; 9: 1030 - 1041 | Link | ||
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | S. Liu et al., J. Biol. Chem., 2015, 290(29): 17894-17908; DOI 10.1074/jbc.M114.607184 | Link | |
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | plasmid | Metafectene PRO | publication | H.-K. Lee, PhD Thesis, 2015, Seoul National University | Link | ||
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | B. von Neubeck et al., Int. J. of Cancer, 2018, 143: 2065–2075, DOI: 10.1002/ijc.31607 | ||
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | plasmid | Metafectene PRO | application note | ![]() |
|||
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | plasmid | CRISPR | Metafectene PRO | publication | B. von Neubeck et al., Int. J. of Cancer, 2018, 143: 2065–2075, DOI: 10.1002/ijc.31607 | ||
MDA-MB-435S |
Human breast cancer metastatic melanoma cell line | ATCC HTB-129 | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | I. Karwaciak et al., Cancers, 2019, 11, 673, doi:10.3390/cancers11050673 | Link | |
MDA-MB-435S |
Human breast cancer metastatic melanoma cell line | ATCC HTB-129 | Human | skin | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | I. Karwaciak et al., Cancers, 2019, 11, 673, doi:10.3390/cancers11050673 | Link | |
MDA-MB-436 |
Human breast cancer cell line | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | L. J. Barlow, Dissertation, 2020, University Graduate School | Link | ||
MDA-MB-436 |
Human breast cancer cell line | Human | breast | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | L. J. Barlow, Dissertation, 2020, University Graduate School | Link | ||
MDA-MB-468 |
Human breast adenocarcinoma cell line | ATCC HTB-132 | Human | breast | cell line | adherent | plasmid | Metafectene PRO | publication | A. Ray et al., Mol. Cancer Res., Aug 2011; 9: 1030 - 1041 | Link | ||
MDCK |
Madin darby canine kidney cell line | ATCC CCL 34 | Dog | urinary system | cell line | adherent | plasmid | Metafectene PRO | application note | ![]() |
|||
MDCK |
Madin darby canine kidney cell line | ATCC CCL 34 | Dog | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | M. Brunati et al., eLife, 2015,4:e08887; DOI: 10.7554/eLife.08887 | Link | |
MDCK |
Madin darby canine kidney cell line | ATCC CCL 34 | Dog | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | S. Liu et al., J. Biol. Chem., Jul 2015; 290: 17894 - 17908 | |||
MDCK |
Madin darby canine kidney cell line | ATCC CCL 34 | Dog | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | E. P. M. van Loon et al., Am. J. Physiol. Renal Physiol., 2015, 309: F359-F368; doi:10.1152/ajprenal.00240.2014 | Link | |
MDCK |
Madin darby canine kidney cell line | ATCC CCL 34 | Dog | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | S. Liu et al., Cell Communication and Signaling, (2018, 16:10; doi.org/10.1186/s12964-018-0223-4 | Link | ||
MDCK |
Madin darby canine kidney cell line | ATCC CCL 34 | Dog | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | M. Norman et al., J. Cell Sci., Jan 2012; 125: 59 - 66 | Link | |
MDCK |
Madin darby canine kidney cell line | ATCC CCL 34 | Dog | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | F. J. Arjona et al., European J. of Physiology, 2019, 471: 845–860, doi.org/10.1007/s00424-018-2234-9 | Link | |
MDCK |
Madin darby canine kidney cell line | ATCC CCL 34 | Dog | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | B. Singh et al., Journal of Cell Science, 2015, 128: 3444-3455; doi:10.1242/jcs.170852 | Link | |
MDCK |
Madin darby canine kidney cell line | ATCC CCL 34 | Dog | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | F. J. Arjona et al., Europ. J. of Physiol. , 2018, doi.org/10.1007/s00424-018-2234-9 | Link | |
MDCK |
Madin darby canine kidney cell line | ATCC CCL 34 | Dog | urinary system | cell line | adherent | plasmid | Metafectene PRO | application note | ![]() |
|||
MDCK |
Madin darby canine kidney cell line | ATCC CCL 34 | Dog | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | S. C. Klinger et al., The FEBS Journal, 2016, 283:2476-2493; doi:10.1111/febs.13758 | Link | |
MDCK |
Madin darby canine kidney cell line | ATCC CCL 34 | Dog | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | C. Seitz, Dissertation, 2012, Otto-von-Guericke-Universität Magdeburg | Link |